New antibody cocktail shields vulnerable patients from COVID-19
NCT ID NCT07473986
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether a medicine called Evusheld can prevent COVID-19 in people with weakened immune systems who did not get protection from vaccines. The study included 88 adults who were at high risk. Researchers tracked how many got sick with COVID-19 symptoms to see if Evusheld helped keep them safe.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARS-COV-2 OMICRON VARIANTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fondazione IRCCS Policlinico San Matteo di Pavia
Pavia, Pavia, 27100, Italy